E
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Sell
Prev Close
$0.33
Volume
--
Avg Vol (90D)
44,041
Market Cap
$26.46M
Dividend & Yield
--
52-Week Range
$0.31 - $0.55
P/E (TTM)
--
EPS (TTM)
-$0.0128
My Lists My Alerts
Weiss Ratings LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Good
Efficiency Index Very Weak
Solvency Index Fair
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta 0.49
Price History LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 15.63%
30-Day Total Return 5.71%
60-Day Total Return -7.50%
90-Day Total Return -18.68%
Year to Date Total Return -10.84%
1-Year Total Return -10.84%
2-Year Total Return -51.32%
3-Year Total Return --
5-Year Total Return --
52-Week High % Change -40.00%
52-Week Low % Change 6.45%
Price LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.55
52-Week Low Price $0.31
52-Week Low Price (Date) Dec 23, 2024
52-Week High Price (Date) May 09, 2024
Valuation LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 26.46M
Enterprise Value 36.09M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.01
Earnings Per Share Growth -87.79%
Price/Earnings To Growth --
Price/Sales (TTM) 3.27
Price/Book (Q) 2.53
Enterprise Value/Revenue (TTM) 3.10
Price $0.37
Enterprise Value/EBITDA (TTM) 37.72
Enterprise Value/EBIT 197.84
Market Cap Category Nano Cap
Dividends and Shares LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 115.28M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 514 664 7700
Address 540, d’Avaugour Street Boucherville, QC J4B 0G6
Website www.groupelslpharma.com
Country Canada
Year Founded --
Profitability LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) 1.56%
Profit Margin -10.46%
Management Effectiveness LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets 0.46%
Return on Equity --
Income Statement LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 11.63M
Total Revenue (TTM) 11.63M
Revenue Per Share $0.10
Gross Profit (TTM) 2.92M
EBITDA (TTM) 956.70K
EBIT (TTM) 182.40K
Net Income (TTM) -1.22M
Net Income Avl. to Common (TTM) -1.22M
Total Revenue Growth (Q YOY) 57.01%
Earnings Growth (Q YOY) 50.18%
EPS Diluted (TTM) -0.01
EPS Diluted Growth (Q YOY) 66.67%
Balance Sheet LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 121.40K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 7.31M
Total Preferred Equity (Q) --
Total Equity (Q) 15.08M
Current Ratio (Q) 1.166
Book Value Per Share (Q) $0.13
Total Assets (Q) 28.10M
Total Current Liabilities (Q) 6.26M
Total Debt (Q) 10.39M
Total Liabilities (Q) 13.02M
Total Common Equity (Q) 15.08M
Cash Flow LSL.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -3.42M
Cash from Financing (TTM) 5.82M
Net Change in Cash (TTM) 140.20K
Levered Free Cash Flow (TTM) -6.70M
Cash from Operations (TTM) -2.27M
Weiss Ratings